ArticleEuropean heart journal. Case reports2025
Transmural breakthrough and epicardial growth of right atrial myxoma: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Myxomas are the most common primary cardiac tumour, typically presenting as a pedunculated mass growing in the left atrium. Clinical presentation may range from dyspnoea, palpitations, and heart failure to sudden cardiac death, depending on location, size, and mobility. In this report, we describe the case of a giant right atrial myxoma with transmural breakthrough and epicardial growth as well as its successful surgical resection. Case summary: A 65 year-old male patient presented with progressive coronary artery disease following prior coronary artery bypass grafting. Cardiac magnetic resonance imaging was performed to assess myocardial vitality, incidentally revealing a round mediastinal tumour of over 6 cm in diameter with compression of the right atrium and the superior and inferior vena cava. As he was experiencing dyspnoea and pectanginous complaints, the patient opted for surgical removal. The epicardial mass was successfully resected under cardiopulmonary bypass and was histologically classified as a myxoma. Discussion: Transmural breakthrough and epicardial growth of cardiac myxomas are extremely rare. Surgical resection can confirm the unexpected diagnosis and alleviate symptoms of heart failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.